$SHPH
Shuttle Pharmaceuticals Holdings, Inc. Stock $shph

$shph Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000149315223007686 Filed on March 15, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue		$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$534.0K	$301.1K	$1.066M
YoY Change	55.91%	-44.9%	47.78%
% of Gross Profit
Research & Development	$1.011M	$439.7K	$1.489M
YoY Change	241.58%	-0.55%	45.68%
% of Gross Profit
Depreciation & Amortization	$1.488K	$1.490K	$5.972K
YoY Change	2.62%	-31.34%	-3.96%
% of Gross Profit
Operating Expenses	$1.545M	$740.8K	$2.554M
YoY Change	141.98%	-25.06%	46.55%
Operating Profit	-$1.545M		-$2.554M
YoY Change	141.98%		46.55%
Interest Expense	$692.2K	-$10.12K	-$875.9K
YoY Change	-694.4%	-101.91%	-265.77%
% of Operating Profit
Other Income/Expense, Net	$569.7K	$0.00	-$474.2K
YoY Change	-1411.33%		-180.25%
Pretax Income	-$975.1K	-$750.9K	-$3.028M
YoY Change	43.01%	63.58%	162.86%
Income Tax		$0.00
% Of Pretax Income
Net Earnings	-$975.1K	-$750.9K	-$3.028M
YoY Change	43.01%	54.89%	162.86%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.07		-$0.29
Diluted Earnings Per Share	-$0.07	-$0.06	-$0.23
COMMON SHARES
Basic Shares Outstanding	13.65M shares	13.59M shares	10.35M shares
Diluted Shares Outstanding	13.64M shares		10.35M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.16M	$8.417M	$8.417M
YoY Change	49196.46%		1567.6%
Cash & Equivalents	$7.169M	$8.417M
Short-Term Investments	$2.990M
Other Short-Term Assets	$200.0K	$161.2K	$161.2K
YoY Change	-50.72%		3209.03%
Inventory
Prepaid Expenses	$203.8K	$161.1K
Receivables	$10.00K
Other Receivables	$0.00
Total Short-Term Assets	$10.37M	$8.578M	$8.578M
YoY Change	2332.03%	1583.3%	1583.28%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.10K	$12.59K	$68.71K
YoY Change	-90.71%	-32.17%	-49.31%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$10.00K	$6.480K	$6.480K
YoY Change	54.32%		0.0%
Total Long-Term Assets	$64.62K	$75.19K	$75.20K
YoY Change	-48.71%	-47.06%	-47.05%
TOTAL ASSETS
Total Short-Term Assets	$10.37M	$8.578M	$8.578M
Total Long-Term Assets	$64.62K	$75.19K	$75.20K
Total Assets	$10.44M	$8.654M	$8.654M
YoY Change	1789.13%	1227.96%	1227.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$450.0K	$116.8K	$116.8K
YoY Change	-34.9%		-85.91%
Accrued Expenses	$180.0K	$173.5K	$173.5K
YoY Change	25.67%		51.59%
Deferred Revenue
YoY Change
Short-Term Debt	$140.0K	$685.5K	$685.5K
YoY Change	-87.41%		-11.72%
Long-Term Debt Due	$620.0K	$0.00	$0.00
YoY Change			-100.0%
Total Short-Term Liabilities	$1.388M	$975.7K	$975.7K
YoY Change	-41.12%	-56.0%	-56.0%
LONG-TERM LIABILITIES
Long-Term Debt	$750.0K	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$1.390M	$0.00	$0.00
YoY Change	3041.24%		-100.0%
Total Long-Term Liabilities	$2.140M	$0.00	$0.00
YoY Change	4736.16%		-100.0%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.388M	$975.7K	$975.7K
Total Long-Term Liabilities	$2.140M	$0.00	$0.00
Total Liabilities	$3.530M	$975.7K	$975.7K
YoY Change	46.96%	-57.2%	-57.2%
SHAREHOLDERS EQUITY
Retained Earnings	-$9.870M	-$8.895M
YoY Change		53.48%
Common Stock	$137.00	$16.57M
YoY Change		299.25%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.906M	$7.678M	$7.678M
YoY Change
Total Liabilities & Shareholders Equity	$10.44M	$8.654M	$8.654M
YoY Change	1789.13%	1227.96%	1227.96%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$975.1K	-$750.9K	-$3.028M
YoY Change	43.01%	54.89%	162.86%
Depreciation, Depletion And Amortization	$1.488K	$1.490K	$5.972K
YoY Change	2.62%	-31.34%	-3.96%
Cash From Operating Activities	-$1.338M	-$679.9K	-$2.710M
YoY Change	114.21%	403.04%	802.47%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$2.954M	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$2.954M	$0.00	$0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$10.02M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$3.044M	-23.32K	$10.62M
YoY Change	478.97%	-104.71%	1444.18%
NET CHANGE
Cash From Operating Activities	-$1.338M	-679.9K	-$2.710M
Cash From Investing Activities	-$2.954M	0.000	0.000
Cash From Financing Activities	$3.044M	-23.32K	$10.62M
Net Change In Cash	-$1.248M	-703.2K	$7.912M
YoY Change	1161.94%	-295.45%	1941.42%
FREE CASH FLOW
Cash From Operating Activities	-$1.338M	-$679.9K	-$2.710M
Capital Expenditures
Free Cash Flow			-$2.710M
YoY Change			802.47%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	us-gaap	Revenues Revenues		usd
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001757499
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent		usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent		usd
CY2022Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent		usd
CY2022Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent		usd
CY2022Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent		usd
CY2022Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent		usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	SHPH	Common Stock To Be Issued CommonStockToBeIssued		usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021	us-gaap	Debt Securities Gain Loss DebtSecuritiesGainLoss		usd
CY2022	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables		usd
CY2021	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent		usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2021	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
CY2022	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2021	us-gaap	Stock Issued1 StockIssued1		usd
CY2021	SHPH	Common Stock Issued For Conversion Of Convertible Debt CommonStockIssuedForConversionOfConvertibleDebt		usd
CY2021	SHPH	Common Stock Issued For Exercise Of Warrants With Settlement Of Notes Payable CommonStockIssuedForExerciseOfWarrantsWithSettlementOfNotesPayable		usd
CY2021	SHPH	Common Stock Issued For Dividend Payable CommonStockIssuedForDividendPayable		usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent		usd
CY2022Q4	us-gaap	Notes Payable NotesPayable		usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount		usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet		usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt		usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41488
CY2022	dei	Entity Registrant Name EntityRegistrantName	Shuttle Pharmaceuticals Holdings, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	82-5089826
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	One Research Court
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 450
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Rockville
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20850
CY2022	dei	City Area Code CityAreaCode	(240)
CY2022	dei	Local Phone Number LocalPhoneNumber	403-4212
CY2022	dei	Security12b Title Security12bTitle	Common Stock
CY2022	dei	Trading Symbol TradingSymbol	SHPH
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	0	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13654127	shares
CY2022	dei	Auditor Firm AuditorFirmId	5041
CY2022	dei	Auditor Name AuditorName	BF Borgers CPA PC
CY2022	dei	Auditor Location AuditorLocation	Lakewood, CO
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8417203	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	504749	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	161148	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4866	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	8578351	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	509615	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12592	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18564	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	6480	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	6480	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	56122	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	116982	usd
CY2022Q4	us-gaap	Assets Assets	8653545	usd
CY2021Q4	us-gaap	Assets Assets	651641	usd
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	116745	usd
CY2021Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	828313	usd
CY2022Q4	us-gaap	Accounts Payable Related Parties Current AccountsPayableRelatedPartiesCurrent	12500	usd
CY2021Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	552	usd
CY2022Q4	us-gaap	Due To Other Related Parties Classified Current DueToOtherRelatedPartiesClassifiedCurrent	98135	usd
CY2021Q4	us-gaap	Due To Other Related Parties Classified Current DueToOtherRelatedPartiesClassifiedCurrent	46947	usd
CY2021Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	331059	usd
CY2022Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	685473	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	685473	usd
CY2021Q4	us-gaap	Notes Payable To Bank Current NotesPayableToBankCurrent	91021	usd
CY2021Q4	us-gaap	Other Notes Payable Current OtherNotesPayableCurrent	73007	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	94025	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	62823	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	66934	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	975676	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	2217331	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	62442	usd
CY2022Q4	us-gaap	Liabilities Liabilities	975676	usd
CY2021Q4	us-gaap	Liabilities Liabilities	2279773	usd
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2021Q4	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	1000
CY2022Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	1212500	usd
CY2021Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	1212500	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	1213	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13603129	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13603129	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	9312152	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9312152	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	136	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	93	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	16572622	usd
CY2021Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	4150867	usd
CY2021Q4	SHPH	Common Stock To Be Issued CommonStockToBeIssued	16340	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8894889	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5795432	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7677869	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1628132	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	8653545	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	651641	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1488530	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1021808	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	198978	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	36500	usd
CY2022	us-gaap	Legal Fees LegalFees	866770	usd
CY2021	us-gaap	Legal Fees LegalFees	684684	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	2554278	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	1742992	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-2554278	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-1742992	usd
CY2022	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	52010	usd
CY2021	us-gaap	Interest Expense Related Party InterestExpenseRelatedParty	46947	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	917879	usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	3841	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-94025	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-579146	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	328687	usd
CY2022	SHPH	Gain On Forgiveness Of Note Payable GainOnForgivenessOfNotePayable	73007	usd
CY2021	SHPH	Gain On Forgiveness Of Note Payable GainOnForgivenessOfNotePayable	62500	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-474170	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	590858	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3028448	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1152134	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-3028448	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1152134	usd
CY2022	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	71009	usd
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	103062	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3099457	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1255196	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10351046	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	9301750	shares
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.29
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.12
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-1690296	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	420000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	407293	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-300336	usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	490067	usd
CY2021	us-gaap	Dividends Preferred Stock DividendsPreferredStock	103062	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1152134	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1628132	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-1628132	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	10008095	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	14098	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	412241	usd
CY2022	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	588524	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	576476	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	403956	usd
CY2022	us-gaap	Dividends Preferred Stock DividendsPreferredStock	71009	usd
CY2022	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	402068	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-3028448	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7677869	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	7677869	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-3028448	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-1152134	usd
CY2022	us-gaap	Depreciation Depreciation	5972	usd
CY2021	us-gaap	Depreciation Depreciation	6218	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-94025	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-579146	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	60860	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	54616	usd
CY2022	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	885505	usd
CY2021	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3389	usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	328687	usd
CY2022	SHPH	Gain On Forgiveness Of Note Payable GainOnForgivenessOfNotePayable	73007	usd
CY2021	SHPH	Gain On Forgiveness Of Note Payable GainOnForgivenessOfNotePayable	62500	usd
CY2022	us-gaap	Debt Securities Gain Loss DebtSecuritiesGainLoss	-12625	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	403956	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	910067	usd
CY2021	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-211455	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	156282	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-7713	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-382881	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	311347	usd
CY2022	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	12500	usd
CY2022	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	-13177	usd
CY2021	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	160	usd
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	51188	usd
CY2021	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	46947	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-66553	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-58468	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2710454	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	10022193	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-50000	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	50000	usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	120000	usd
CY2021	us-gaap	Proceeds From Other Short Term Debt ProceedsFromOtherShortTermDebt	73007	usd
CY2022	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	600715	usd
CY2021	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	494925	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	10622908	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	687932	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	7912454	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	387596	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	504749	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	117153	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8417203	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	504749	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	39201	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	293	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	16340	usd
CY2022	SHPH	Common Stock Issued For Conversion Of Convertible Debt CommonStockIssuedForConversionOfConvertibleDebt	588524	usd
CY2022	SHPH	Common Stock Issued For Exercise Of Warrants With Settlement Of Notes Payable CommonStockIssuedForExerciseOfWarrantsWithSettlementOfNotesPayable	576476	usd
CY2022	SHPH	Common Stock Issued For Dividend Payable CommonStockIssuedForDividendPayable	402068	usd
CY2022Q2	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	2-for-1 reverse stock split
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_z7FqKCBNN4ib" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86D_zWbM15spctma">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions. The Company bases its estimates and assumptions on current facts, historical experience, and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected. Significant estimates in the accompanying financial statements include useful lives of property and equipment, valuation of derivatives, valuation of warrants, and the valuation allowance on deferred tax assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2020	SHPH	Proceeds From Contract Awards For Research And Development ProceedsFromContractAwardsForResearchAndDevelopment	845820	usd
CY2022Q2	SHPH	Payments To Invoices In Research And Development PaymentsToInvoicesInResearchAndDevelopment	791017	usd
CY2022	SHPH	Payments To Invoices In Research And Development PaymentsToInvoicesInResearchAndDevelopment	282643	usd
CY2022	SHPH	Research And Development Deficit Net ResearchAndDevelopmentDeficitNet	83868	usd
CY2022Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	0	usd
CY2021Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	94025	usd
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	356810	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	145593	shares
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	127466	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	127466	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	114874	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	108902	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12592	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	18564	usd
CY2022	us-gaap	Depreciation Depreciation	5972	usd
CY2021	us-gaap	Depreciation Depreciation	6218	usd
CY2022	us-gaap	Lessee Operating Lease Assumptions And Judgments Discount Rate Description LesseeOperatingLeaseAssumptionsAndJudgmentsDiscountRateDescription	The interest rate used to determine the present value is our incremental borrowing rate, estimated to be 10%, as the interest rate implicit in most of our leases is not readily determinable.
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	70175	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	74028	usd
CY2018Q4	us-gaap	Operating Lease Payments OperatingLeasePayments	6480	usd
CY2018Q4	SHPH	Lessee Operating Lease Increases Percentage LesseeOperatingLeaseIncreasesPercentage	0.03	pure
CY2018Q4	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2023-10-31
CY2018Q4	us-gaap	Security Deposit SecurityDeposit	6480	usd
CY2022Q4	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P12M
CY2022Q4	SHPH	Office Lease OfficeLease	265207	usd
CY2021Q4	SHPH	Office Lease OfficeLease	265207	usd
CY2022Q4	SHPH	Accumulated Amortization On Right Of Use Assets AccumulatedAmortizationOnRightOfUseAssets	209085	usd
CY2021Q4	SHPH	Accumulated Amortization On Right Of Use Assets AccumulatedAmortizationOnRightOfUseAssets	148225	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	56122	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	116982	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	62823	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	129376	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	62823	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	66934	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	62442	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	64800	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	64800	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1977	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	62823	usd
CY2021Q4	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	In December of 2021 the maturity dates of these loans were extended to June 30, 2022. In July of 2022 the notes were extended to June 30, 2023.
CY2021Q2	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	In July of 2022 the notes were extended to June 30, 2023.
CY2021Q1	us-gaap	Medium Term Notes MediumTermNotes	73007	usd
CY2021Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.01	pure
CY2021Q1	us-gaap	Short Term Debt Description ShortTermDebtDescription	No more than 25% of the amount forgiven can be attributable to non-payroll costs.
CY2020Q2	us-gaap	Medium Term Notes MediumTermNotes	62500	usd
CY2020Q2	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.01	pure
CY2020Q2	us-gaap	Short Term Debt Description ShortTermDebtDescription	No more than 25% of the amount forgiven can be attributable to non-payroll costs.
CY2022Q4	SHPH	Loan Forgiveness LoanForgiveness	-73007	usd
CY2021Q4	SHPH	Loan Forgiveness LoanForgiveness	-62500	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	73007	usd
CY2021Q4	us-gaap	Notes Payable NotesPayable	500000	usd
CY2021Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.10	pure
CY2021Q4	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2022-12-28
CY2021Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	500000	shares
CY2021Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.00
CY2021Q4	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	5075	usd
CY2022Q3	us-gaap	Interest Paid InterestPaid	16667	usd
CY2022Q4	us-gaap	Interest Paid InterestPaid	21712	usd
CY2022Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	365000	usd
CY2022Q1	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	224985	usd
CY2022Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.06	pure
CY2022Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.06	pure
CY2022Q1	us-gaap	Debt Conversion Converted Instrument Rate DebtConversionConvertedInstrumentRate	0.50	pure
CY2022Q1	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	36500	usd
CY2022Q1	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	22250	usd
CY2022Q4	us-gaap	Debt Securities Gain Loss DebtSecuritiesGainLoss	-12625	usd
CY2022Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	125000	usd
CY2022Q3	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.10	pure
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	500000	usd
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	408979	usd
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	91021	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	408979	usd
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13603129	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	9312152	shares
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1430582	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	197273	shares
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight	180280	shares
CY2022	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	336810	shares
CY2018Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	120250	usd
CY2022Q4	us-gaap	Share Price SharePrice	13.88
CY2022	us-gaap	Warrant Exercise Price Decrease WarrantExercisePriceDecrease	13.88
CY2022	us-gaap	Warrant Exercise Price Increase WarrantExercisePriceIncrease	20.82
CY2022	us-gaap	Common Stock Convertible Conversion Price Decrease CommonStockConvertibleConversionPriceDecrease	12.49
CY2022	us-gaap	Common Stock Convertible Conversion Price Increase CommonStockConvertibleConversionPriceIncrease	13.88
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.8487	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.8550	pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y29D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P2Y3M29D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0245	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0073	pure
CY2022	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	1607044	shares
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-635974	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-153748	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-249847	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-60401	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	0	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	-83975	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	66214	usd
CY2022	SHPH	Income Tax Reconciliation Foreign Income Tax Permanent Differences IncomeTaxReconciliationForeignIncomeTaxPermanentDifferences	-21355	usd
CY2021	SHPH	Income Tax Reconciliation Foreign Income Tax Permanent Differences IncomeTaxReconciliationForeignIncomeTaxPermanentDifferences	19381	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	924936	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	194768	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	1173451	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	768120	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	7801	usd
CY2021Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	7479	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	399644	usd
CY2021Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	7788	usd
CY2022Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	45574	usd
CY2021Q4	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	45574	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	215229	usd
CY2021Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	87801	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1841698	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	916762	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1841698	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	916762	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	4011180	usd
CY2021Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	120000	usd
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	426243	usd

Files In Submission

Name	View Source	Status
0001493152-23-007686-index-headers.html	Edgar Link	pending
0001493152-23-007686-index.html	Edgar Link	pending
0001493152-23-007686.txt	Edgar Link	pending
0001493152-23-007686-xbrl.zip	Edgar Link	pending
ex10-44.htm	Edgar Link	pending
ex10-45.htm	Edgar Link	pending
ex10-46.htm	Edgar Link	pending
ex23-1.htm	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
ex99-1.htm	Edgar Link	pending
ex99-1_001.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-k.htm	Edgar Link	pending
form10-k_001.jpg	Edgar Link	pending
form10-k_002.jpg	Edgar Link	pending
form10-k_003.jpg	Edgar Link	pending
form10-k_004.jpg	Edgar Link	pending
form10-k_005.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-k_htm.xml	Edgar Link	completed
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
shph-20221231.xsd	Edgar Link	pending
shph-20221231_cal.xml	Edgar Link	unprocessable
shph-20221231_def.xml	Edgar Link	unprocessable
shph-20221231_lab.xml	Edgar Link	unprocessable
shph-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SHPH
Shuttle Pharmaceuticals Holdings, Inc. Stock $shph

2023 Q1 Form 10-K Financial Statement

#000149315223007686 Filed on March 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHPH Shuttle Pharmaceuticals Holdings, Inc. Stock $shph

2023 Q1 Form 10-K Financial Statement

#000149315223007686 Filed on March 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHPH
Shuttle Pharmaceuticals Holdings, Inc. Stock $shph